NorthLanding Financial Partners’s Johnson & Johnson JNJ Stock Holding History

NorthLanding Financial Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,269	Closed	-$224K	–	68
2022 Q4	$224K	Buy	1,269 +16	+1%	+$2.76K	0.16%	61
2022 Q3	$205K	Buy	+1,253	New	+$212K	0.16%	62

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NorthLanding Financial Partners's JNJ Position: Q1 2023 in Review

NorthLanding Financial Partners sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 1,269 shares — an estimated $224K sold.

NorthLanding Financial Partners first reported a position in JNJ in Q3 2022 and held it in 2 quarters. The position peaked at $224K in Q4 2022. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

NorthLanding Financial Partners reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
NorthLanding Financial Partners sold 1,269 Johnson & Johnson shares in Q1 2023, an estimated $224K.
NorthLanding Financial Partners first reported a position in Johnson & Johnson in Q3 2022 and held it in 2 quarters.
NorthLanding Financial Partners's Johnson & Johnson position peaked at $224K in Q4 2022.
3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on NorthLanding Financial Partners's 13F filing for Q1 2023, filed 27 Apr 2023.